JP2024539132A5 - - Google Patents

Info

Publication number
JP2024539132A5
JP2024539132A5 JP2024523601A JP2024523601A JP2024539132A5 JP 2024539132 A5 JP2024539132 A5 JP 2024539132A5 JP 2024523601 A JP2024523601 A JP 2024523601A JP 2024523601 A JP2024523601 A JP 2024523601A JP 2024539132 A5 JP2024539132 A5 JP 2024539132A5
Authority
JP
Japan
Prior art keywords
alkyl
methyl
groups
optionally substituted
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024523601A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024539132A (ja
Filing date
Publication date
Priority claimed from GBGB2115156.8A external-priority patent/GB202115156D0/en
Application filed filed Critical
Publication of JP2024539132A publication Critical patent/JP2024539132A/ja
Publication of JP2024539132A5 publication Critical patent/JP2024539132A5/ja
Pending legal-status Critical Current

Links

JP2024523601A 2021-10-21 2022-10-21 がんの治療における使用のためのヘテロ環式化合物 Pending JP2024539132A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2115156.8 2021-10-21
GBGB2115156.8A GB202115156D0 (en) 2021-10-21 2021-10-21 Novel compounds
PCT/GB2022/052689 WO2023067355A1 (en) 2021-10-21 2022-10-21 Heterocyclic compounds for use in the treatment of cancer

Publications (2)

Publication Number Publication Date
JP2024539132A JP2024539132A (ja) 2024-10-28
JP2024539132A5 true JP2024539132A5 (cg-RX-API-DMAC7.html) 2026-04-07

Family

ID=78805918

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024523601A Pending JP2024539132A (ja) 2021-10-21 2022-10-21 がんの治療における使用のためのヘテロ環式化合物
JP2024523445A Pending JP2024542949A (ja) 2021-10-21 2022-10-21 がん治療での使用のためのヘテロ環式化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024523445A Pending JP2024542949A (ja) 2021-10-21 2022-10-21 がん治療での使用のためのヘテロ環式化合物

Country Status (24)

Country Link
US (2) US20240425511A1 (cg-RX-API-DMAC7.html)
EP (2) EP4419527A1 (cg-RX-API-DMAC7.html)
JP (2) JP2024539132A (cg-RX-API-DMAC7.html)
KR (1) KR20240099274A (cg-RX-API-DMAC7.html)
CN (2) CN119053600A (cg-RX-API-DMAC7.html)
AR (1) AR127431A1 (cg-RX-API-DMAC7.html)
AU (1) AU2022374050A1 (cg-RX-API-DMAC7.html)
CA (1) CA3233255A1 (cg-RX-API-DMAC7.html)
DK (1) DK4419526T3 (cg-RX-API-DMAC7.html)
ES (1) ES3008687T3 (cg-RX-API-DMAC7.html)
FI (1) FI4419526T3 (cg-RX-API-DMAC7.html)
GB (1) GB202115156D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20250334T1 (cg-RX-API-DMAC7.html)
HU (1) HUE070568T2 (cg-RX-API-DMAC7.html)
IL (1) IL311922A (cg-RX-API-DMAC7.html)
LT (1) LT4419526T (cg-RX-API-DMAC7.html)
MX (1) MX2024004874A (cg-RX-API-DMAC7.html)
PL (1) PL4419526T3 (cg-RX-API-DMAC7.html)
PT (1) PT4419526T (cg-RX-API-DMAC7.html)
RS (1) RS66620B1 (cg-RX-API-DMAC7.html)
SI (1) SI4419526T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202500123T1 (cg-RX-API-DMAC7.html)
TW (1) TW202334150A (cg-RX-API-DMAC7.html)
WO (2) WO2023067355A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202115156D0 (en) * 2021-10-21 2021-12-08 Artios Pharma Ltd Novel compounds
WO2025077896A1 (zh) * 2023-10-12 2025-04-17 上海湃隆生物科技有限公司 一种DNA聚合酶theta抑制剂及其应用
CN118084767B (zh) * 2024-04-02 2025-06-17 康龙化成手性医药技术(宁波)有限公司 一种外型-6-氟甲基-3-氮杂双环[3,1,0]己烷盐酸盐及其衍生物的合成方法
WO2025214463A1 (zh) * 2024-04-13 2025-10-16 正大天晴药业集团股份有限公司 含有三并环结构的化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10760081B2 (en) 2015-10-07 2020-09-01 New York University Compositions and methods for enhancing CRISPR activity by POLQ inhibition
EP4010080B1 (en) * 2019-08-09 2023-09-27 Artios Pharma Limited Heterocyclic compounds for use in the treatment of cancer
GB202115156D0 (en) * 2021-10-21 2021-12-08 Artios Pharma Ltd Novel compounds
GB202115158D0 (en) * 2021-10-21 2021-12-08 Artios Pharma Ltd Novel compounds
GB202115150D0 (en) * 2021-10-21 2021-12-08 Artios Pharma Ltd Novel compounds

Similar Documents

Publication Publication Date Title
JP5775070B2 (ja) ヤヌスキナーゼ阻害剤としてのピラゾール−4−イル−ピロロ[2,3−d]ピリミジンおよびピロール−3−イル−ピロロ[2,3−d]ピリミジンのN−(ヘテロ)アリール−ピロリジン誘導体
ES2985528T3 (es) Nuevos compuestos y composiciones farmacéuticas de los mismos para el tratamiento de enfermedades
AU2015296322B2 (en) 2-amino-pyrido[2,3-d]pyrimidin-7(8h)-one derivatives as CDK inhibitors and uses thereof
CN105294683B (zh) Cdk类小分子抑制剂的化合物及其用途
AU2015291522B2 (en) Substituted urea derivatives and pharmaceutical uses thereof
WO2025049641A1 (en) Kras modulators and uses thereof
ES2871524T3 (es) Pirrolo[2,3-d]pirimidinilo, pirrolo[2,3-b]pirazinilo y pirrolo[2,3-d]piridinil acrilamidas
EP3755699A1 (en) Shp2 phosphatase inhibitors and methods of use thereof
JP2022548095A (ja) 接着分解剤及びその使用方法
ES2973661T3 (es) Compuestos de cetona bicíclica y procedimientos de uso de los mismos
CA3085937A1 (en) Diazaindole compounds
JP2019512505A5 (cg-RX-API-DMAC7.html)
WO2021074279A1 (en) Spiro-fused tricyclic map4k1 inhibitors
WO2025194054A1 (en) Spirocyclic compounds as modulators of kras and uses thereof
ES2892624T3 (es) Compuestos tricíclicos y composiciones como inhibidores de cinasas
EP4041730B1 (en) Substituted bicyclic heteroaryl compounds
CN111867592A (zh) 用于治疗异常细胞增殖的杂环化合物
EP3548484A1 (en) Bicyclic amide compounds and methods of use thereof
WO2025194057A1 (en) Macrocyclic compounds as modulators of kras and uses thereof
CA3050567A1 (en) Substituted dihydroimidazopyridinediones as mknk1 and mknk2 inhibitors
EP4051388A1 (en) Substituted pyrazole compounds as toll receptor inhibitors
JP2023517539A (ja) Rna結合タンパク質またはrna修飾タンパク質を標的とする化合物
WO2025240582A1 (en) Macrocyclic compounds as modulators of kras and uses thereof
EP2721030A1 (en) Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives
TWI838644B (zh) 芳甲醯取代的三環化合物及其製法和用途